AMICUS THERAPEUTICS INC (FOLD)

US03152W1099 - Common Stock

10.71  -0.11 (-1.02%)

After market: 10.71 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
305.5M
17.09%		329.2M
7.76%		399.356M
21.31%		541.82M
35.67%
EBITDA
YoY % growth
-200.19M
15.94%		-200.16M
0.01%		-68.204M
65.93%		43.854M
164.30%		N/AN/AN/AN/A
EBIT
YoY % growth
-206.4M
16.44%		-205.5M
0.44%		-76.077M
62.98%		36.744M
148.30%
Operating Margin
-67.56%-62.42%-19.05%6.78%
EPS
YoY % growth
-0.92
11.54%		-0.82
10.87%		-0.51
37.80%		0.00
100.89%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.07
62.85%
Revenue
Q2Q % growth		113.41M
31.41%
EBITDA
Q2Q % growth		-14.637MN/AN/AN/AN/A
EBIT
Q2Q % growth		-8.72M
76.81%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.11
42.11%		-0.06-0.05-83.13%
Q3 2023
Q2Q % growth		 -0.07
41.67%		-0.080.019.17%
Q2 2023
Q2Q % growth		 -0.15
28.57%		-0.13-0.02-19.24%
Q1 2023
Q2Q % growth		 -0.18
40.00%		-0.15-0.03-20.32%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 115.082M
30.63%		116.62M-1.538M-1.32%
Q3 2023
Q2Q % growth		 103.5M
26.68%		103.39M110K0.11%
Q2 2023
Q2Q % growth		 94.5M
17.10%		91.665M2.835M3.09%
Q1 2023
Q2Q % growth		 86.3M
9.66%		84.745M1.555M1.83%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-5.37% -27.47% -66.69% -94.04%
Revenue-0.69% -2.57% -0.32% -0.68%